chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nausea, Pyrexia
Clinical narrative: Fever; Chills; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 26Apr2021 at 14:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 27Apr2021 at 05:00, about 15 hours after second dose of vaccination, the patient experienced fever, chills, and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment over the counter medication at home. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, and nausea was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus / Ringing in ears; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 23Apr2021 at 12:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included tubes in ears when younger but never tinnitus (ear tube insertion). The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. On 23Apr2021, the patient experienced tinnitus and ringing in ears. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus and ringing in ears was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Dyspnoea
Clinical narrative: Continuing to have difficulty breathing and coughing when I get short of breath; Continuing to have difficulty breathing and coughing when I get short of breath; Some tightness in chest; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 14Apr2021 at 10:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in left arm on 24Mar2021 at 10:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient previously received diclofenac (VOLTAREN) and experienced drug allergy. On 15Apr2021 at 14:00, the patient experienced going on week two continuing to had difficulty breathing and coughing when she gets short of breath and some tightness in chest. The clinical outcome of the events continuing to have difficulty breathing and coughing when she get short of breath and some tightness in chest was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Bone pain, Chills, Fatigue, Feeling cold
Clinical narrative: Tired; Bones started hurting.; Headache; Felt nauseous; Lower back was hurting; Fever; Chills; Felt cold medicine spreading; Sensation of numbness; Arm felt a little heavy; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 07:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Apr2021 at 22:00, the patient experienced a feeling of cold medicine spreading, a sensation of numbness, arm felt a little heavy and had fever and chills throughout the night of vaccination. On 23Apr2021, second day, the patient felt tired, bones started hurting, headache, felt nauseous and lower back was hurting a lot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with ibuprofen (ADVIL) from an unknown date. The clinical outcome of the events felt cold medicine spreading, a sensation of numbness, arm felt a little heavy, fever, chills, felt tired, bones started hurting, headache, felt nauseous and lower back was hurting a lot was recovered on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Limb discomfort, Nausea, Pyrexia
Clinical narrative: Tired; Bones started hurting.; Headache; Felt nauseous; Lower back was hurting; Fever; Chills; Felt cold medicine spreading; Sensation of numbness; Arm felt a little heavy; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 07:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Apr2021 at 22:00, the patient experienced a feeling of cold medicine spreading, a sensation of numbness, arm felt a little heavy and had fever and chills throughout the night of vaccination. On 23Apr2021, second day, the patient felt tired, bones started hurting, headache, felt nauseous and lower back was hurting a lot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with ibuprofen (ADVIL) from an unknown date. The clinical outcome of the events felt cold medicine spreading, a sensation of numbness, arm felt a little heavy, fever, chills, felt tired, bones started hurting, headache, felt nauseous and lower back was hurting a lot was recovered on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Rash papular
Clinical narrative: Small red bumps near the injection spot located in the upper forearm.; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: BUD/ew0172) via an unspecified route of administration on 21Apr2021 at 14:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not have any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Apr2021, the patient experienced small red bumps near the injection spot located in the upper forearm. No therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the event small red bumps near the injection spot located in the upper forearm was unknown at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Leg pain in lower left lane; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 24Mar2021 at 14:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included varicose veins in lower left leg. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ramipril (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN) and sertraline (MANUFACTURER UNKNOWN) all were taken for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced leg pain in lower left lane. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measure was taken as a result of event leg pain in lower left lane which included unspecified treatment and the patient had ultrasound of leg. On an unknown date, the patient underwent ultrasound scan and the result was unknown. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event leg pain in lower left lane was not resolved at the time of this report. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on an unknown date in 2021 as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Disturbance in attention, Memory impairment
Clinical narrative: Inability to concentrate comprehend new data or apply critical thinking; forgetfulness; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 26Apr2021 at 09:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included degenerative joint disease in lumbar spine. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included gabapentin 300mg per night (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date if unknown if ongoing. On 27Apr2021 at 07:00, the patient experienced inability to concentrate, comprehend new data, or apply critical thinking and forgetfulness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events inability to concentrate, comprehend new data, or apply critical thinking and forgetfulness was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Antinuclear antibody, Oral herpes
Clinical narrative: Have never had a fever blister- until now; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Fl3248) via an unspecified route of administration in the right arm on 22Jan2021 at 10:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, ankylosing spondylitis and allergy to sulfa (sulfonamide allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 24Apr2021 at 14:00, the patient experienced fever blister. The patient never had a fever blister until then. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. On an unknown date, the patient underwent antinuclear antibody (ANA)test and the result was positive. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fever blister was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain in extremity
Clinical narrative: Extremely sore arm; Pain up into neck; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 12Y230) via an unspecified route of administration in the left arm on 03Apr2021 at 11:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic pain from torn rotator cuffs and anxiety. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included atorvastatin calcium (LIPITOR), amlodipine besilate (NORVASC), oxycodone (MANUFACTURER UNKNOWN), amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL) and alprazolam (XANAX) all for unknown indication from an unknown date and unknown if ongoing. On 03Apr2021 at 18:00, the patient experienced extremely sore arm and pain up into neck. It was reported that the neck still hurts a month later before 2nd shot, and the patient felt like had slept on neck wrong every day. The patient did not have any neck pain before vaccine and never been treated for neck pain. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether the patient had received any therapeutic measures for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extremely sore arm and pain up into neck were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Abnormal dreams, Fatigue, Feeling abnormal, Memory impairment
Clinical narrative: Wild weird dreams; Many every night also very tired; Brain fog; Forgetfull; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 22Apr2021 at 16:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported and the patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of the vaccination. On 22Apr2021 at 22:30, the patient experienced wild weird dreams, many every night also very tired and brain fog and forgetful. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events wild weird dreams, many every night also very tired, and brain fog and forgetful was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Swelling face
Clinical narrative: Swelling of face; itchiness of face and hands; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: NDC # 59267-1000-02) via an unspecified route of administration in the left arm on 26Apr2021 at 13:00 (at the age of 47-years-old)  as a single dose for COVID-19 immunisation. Medical history included seasonal allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included melatonin (MANUFACTURER UNKNOWN) and vitamin d nos (MANUFACTURER UNKNOWN); both taken for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 05Apr2021 at 13:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. On 27Apr2021 at 00:00, the patient experienced swelling of face and itchiness of face and hands. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling of face and itchiness of face and hands was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain, Pain in extremity
Clinical narrative: Sore arm; Body aches; Mild headache; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 26Apr2021 at 11:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included gabapentin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 05Apr2021 at 11:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 26Apr2021 at 21:00, 10 hours after the shot, the patient experienced sore arm, body aches and mild headache. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, body aches and mild headache was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash pruritic, SARS-CoV-2 test
Clinical narrative: I have a rash that has many characteristics.  On my face it is like a sheet, on my arm it is a red itchy rash, slightly raised on a finger it is raw and oozing and on my leg it is red and breaking the; On my face it is like a sheet, on my arm it is a red itchy rash, slightly raised on a finger it is raw and oozing and on my leg it is red and breaking the skin.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 14Mar2021 at 10:30(at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included hairy cell leukemia. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 14Feb2021 at 11:00(at the age of 62-year-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 16:15, the patient experienced had a rash that had many characteristics. On the face it had like a sheet, on the arm it had a red itchy rash, slightly raised on a finger it is raw and oozing and on the leg it had red and breaking the skin. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of a rash that had many characteristics. On the face it is like a sheet, on the arm it is a red itchy rash, slightly raised on a finger it is raw and oozing and on the leg it red and breaking the skin and included treatment with washing, rubbing alcohol and Benadryl. On 20Apr2021, the patient underwent saliva test and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events, had a rash that had many characteristics, On the face it like a sheet, on the arm it had a red itchy rash, slightly raised on a finger it had raw and oozing and on my leg it red and breaking the skin was recovering at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Infectious mononucleosis
Clinical narrative: was diagnosed with Mononucleosis; This is a spontaneous report from Pfizer-sponsored program. A contactable consumer (patients mother) Parent reported for a patient (reporters son).   An unspecified age male received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number was not reported, Expiry date was not reported) via an unspecified route of administration on an unspecified date in Apr2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient received 1st dose of the Pfizer Covid-19 vaccine 3 weeks ago and was diagnosed with Mononucleosis on 19Apr2021 and is currently taking steroids. His second dose was scheduled on 26Apr2021. The reporter wanted to ask if it was okay for her son to take the 2nd dose while under steroid medication. Treatment received for the event of steroids. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Gingival blister, Noninfective gingivitis, Oral mucosal blistering, Stomatitis
Clinical narrative: Blister like sores on roof of mouth and gums; Blister like sores on gums; Blister like sores on roof of mouth; sores on gums; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously received cefaclor (CECLOR) on an unknown date for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the arm left on 25Mar2021 at 09:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 24Apr2021 at 08:00, the patient experienced blister like sores on roof of mouth and gums. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events blister like sores on roof of mouth and gums were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Eating disorder, Headache, Insomnia, Nausea, Pyrexia
Clinical narrative: Fever; Headache; Sick to stomach; Trouble eating; Insomnia/ trouble sleeping for almost 48 hours; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 24Apr2021 at 13:15 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included PROPRANOL, ABILIFY, WELLBUTRIN, and ALLOPURINOL, from an unknown start date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 03Apr2021 at 13:30 at the age of 28-year-old as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021, the patient experienced fever, headache, sick to stomach, trouble eating, insomnia/ trouble sleeping for almost 48 hours. The patient could almost fall asleep in a haze but then had been shooting back awake. The patient had never felt like he was fully asleep. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the event fever, headache, sick to stomach, trouble eating, insomnia, and trouble sleeping for almost 48 hours were recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Lymphadenopathy, Paraesthesia, Paraesthesia oral, Pharyngeal swelling
Clinical narrative: Tingling in tongue; Minor internal throat swelling; Severe dry mouth; Swollen glands in throat; Tingling in hands; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 20Apr2021 at 12:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis (MS) and known allergies to penicillin and sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included phentermine (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 13:15, the patient experienced tingling in hands, tingling in tongue, severe dry mouth, swollen glands in throat and minor internal throat swelling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingling in hands, tingling in tongue, severe dry mouth, swollen glands in throat and minor internal throat swelling were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Eye swelling, Tenderness
Clinical narrative: Eye on right side of face swollen; Slight bruise; Tender to touch; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old, non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration on 19Apr2021 at 16:15 in left arm (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration on 22Mar2021 at 16:00 in left arm as a single dose for COVID-19 immunisation. On 21Apr2021, at 04:30, 36 hours after second dose the patient woke up to eye on right side of face swollen, slight bruise and tender to touch. She had never heard of this as being a side effect. Plus, her injection was in left arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events of eye on right side of face swollen, slight bruise and tender to touch were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Body temperature, Body temperature increased, Decreased appetite
Clinical narrative: Temp between 99.8-100.6; Body aches significant; Joint pain; Restlessness in bed due to pain; Loss of appetite; Nausea; Diarrhea; Weakness; Tiredness; Arm pain; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 22Apr2021 at 13:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic pain, back instrumentation, hypothyroidism, depression, bone on bone knees needing surgery, partially recovered foot fracture and lactose intolerance. The patient has known allergy to adhesive on butrans patch. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), celecoxib (CELEBREX), duloxetine (MANUFACTURER UNKNOWN) and methadone (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 01Apr2021 at 13:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 08:00, the patient experienced temp between 99.8-100.6, body aches significant, joint pain, restlessness in bed due to pain, loss of appetite, nausea, diarrhea, weakness, tiredness and arm pain. On the same day, the patient underwent body temperature test and the result was 99.8-100.6 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with unspecified pain meds. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event body aches significant, joint pain, restlessness in bed due to pain, loss of appetite, nausea, diarrhea, weakness, tiredness and arm pain was resolved on 27Apr2021; while that of the event temp between 99.8-100.6 was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Nausea, Pain, Pain in extremity
Clinical narrative: Temp between 99.8-100.6; Body aches significant; Joint pain; Restlessness in bed due to pain; Loss of appetite; Nausea; Diarrhea; Weakness; Tiredness; Arm pain; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 22Apr2021 at 13:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic pain, back instrumentation, hypothyroidism, depression, bone on bone knees needing surgery, partially recovered foot fracture and lactose intolerance. The patient has known allergy to adhesive on butrans patch. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), celecoxib (CELEBREX), duloxetine (MANUFACTURER UNKNOWN) and methadone (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 01Apr2021 at 13:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 08:00, the patient experienced temp between 99.8-100.6, body aches significant, joint pain, restlessness in bed due to pain, loss of appetite, nausea, diarrhea, weakness, tiredness and arm pain. On the same day, the patient underwent body temperature test and the result was 99.8-100.6 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with unspecified pain meds. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event body aches significant, joint pain, restlessness in bed due to pain, loss of appetite, nausea, diarrhea, weakness, tiredness and arm pain was resolved on 27Apr2021; while that of the event temp between 99.8-100.6 was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Restlessness
Clinical narrative: Temp between 99.8-100.6; Body aches significant; Joint pain; Restlessness in bed due to pain; Loss of appetite; Nausea; Diarrhea; Weakness; Tiredness; Arm pain; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 22Apr2021 at 13:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic pain, back instrumentation, hypothyroidism, depression, bone on bone knees needing surgery, partially recovered foot fracture and lactose intolerance. The patient has known allergy to adhesive on butrans patch. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), celecoxib (CELEBREX), duloxetine (MANUFACTURER UNKNOWN) and methadone (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 01Apr2021 at 13:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 08:00, the patient experienced temp between 99.8-100.6, body aches significant, joint pain, restlessness in bed due to pain, loss of appetite, nausea, diarrhea, weakness, tiredness and arm pain. On the same day, the patient underwent body temperature test and the result was 99.8-100.6 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with unspecified pain meds. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event body aches significant, joint pain, restlessness in bed due to pain, loss of appetite, nausea, diarrhea, weakness, tiredness and arm pain was resolved on 27Apr2021; while that of the event temp between 99.8-100.6 was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia, Vaccination site pain, Vertigo
Clinical narrative: Injection site pain; Headache; Fever; Chills; Vertigo; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 23Apr2021 at 15:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram (MANUFACTURER UNKNOWN), for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 02Apr2021 at 16:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 19:00, the patient experienced injection site pain for 4 days, headache, fever, chills and vertigo. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of reported events. The clinical outcome of the event injection site pain was recovered on 27Apr2021, after the duration of 4 days whereas headache, fever, chills and vertigo were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm was just a little sore; This is a spontaneous report from a contactable consumer, the patient. A 18-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm left on 25Apr2021 at 13:45 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. The medical history included depression. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included fish oil (OMEGA-3), sertraline (MANUFACTURER UNKNOWN), trazodone (MANUFACTURER UNKNOWN) and bupropion (MANUFACTURER UNKNOWN), all from unknown dates for unknown indications and unknown if ongoing. On 26Apr2021 at 13:00, the patient's arm was just a little sore after. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm was just a little sore was recovered on an unknown date in Apr2021.    No follow-up attempts are needed. No further information is expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Swelling
Clinical narrative: Armpit of the arm that had the shot is swollen and hurts.; Armpit of the arm that had the shot is swollen and hurts.; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 at 10:15 (at the age of 21-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received diphenhydramine hydrochloride (BENADRYL) and experienced drug allergy. On 24Apr2021, the patient's armpit of the arm that had the shot was swollen and caused hurt. It was reported that both swelling and pain were not that bad they were noticeable even when the arm was down and resting. The events did not result in doctor or other healthcare professional office/clinic visits, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events armpit of the arm that had the shot swollen and hurts were resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Insomnia, Pain
Clinical narrative: Next day tired mild fever by 5 pm chillsand fever spiking over the next hrs to 102; Next day tired mild fever by 5 pm chillsand fever spiking over the next hrs to 102; Next day tired mild fever by 5 pm chillsand fever spiking over the next hrs to 102; 12 hrs after second shot body aches,can't get out of bed and can't sleep.; 12 hrs after second shot body aches,can't get out of bed and can't sleep.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 10Apr2021 at 10:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure and anxiety. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included valsartan (MANUFACTURER UNKNOWN), clonazepam (MANUFACTURER UNKNOWN), cyclobenzaprine hydrochloride (FLEXERIL), tocopherol (VITAMIN E), cyanocobalamin (MANUFACTURER UNKNOWN) and multivitamins (reported as multi); all for unknown indication from an unknown date and unknown if ongoing.  The patient previously received the first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 20Apr2021 as a single dose for COVID-19 immunisation. On 10Apr2021 at 22:00,12 hours after second shot the patient experienced body aches, cannot get out of bed and cannot sleep. On 11Apr2021, the next day at 12:00, the patient experienced tired and mild fever. On 11Apr2021 the next day at 17:00, the patient experienced chills. The patient reported soaked two sets of night clothes and two sets of sheets. On 11Apr2021, the patient underwent body temperature test and the result was 102 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events 12 hours after second shot body aches, cannot get out of bed and cannot sleep, next day tired mild fever by 5 pm chills and fever spiking over the next hours to102 was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.